Michal Lazniewski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michal Lazniewski has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Dariusz Plewczynski
Centre of New Technologies, University of Warsaw, S. Banacha 2c, 02-097, Warsaw, Poland
2 shared publications Achilleas Moschos
Laboratory of Molecular OncoSignalling, IMol Polish Academy of Sciences, Warsaw, Poland
1 shared publication- Agnieszka Goral
Department of Immunology, Medical University of Warsaw, Warsaw, Poland
1 shared publication - Agnieszka Graczyk-Jarzynka
Department of Immunology Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland
1 shared publication Agnieszka Kraft
Laboratory of Functional and Structural Genomics, Centre of New Technologies, University of Warsaw, Warsaw, Poland
1 shared publication- Aleksander Ślusarczyk
Department of General, Oncological, and Functional Urology, Medical University of Warsaw, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
MLK4 orchestrates macrophage-induced triple-negative breast cancer invasion and ECM remodeling via enhanced paracrine signaling and NF-κB-MMP axis activation
Tumor-associated macrophages (TAMs) are important mediators of triple-negative breast cancer (TNBC) progression, yet the molecular mechanisms driving this process remain incompletely defined. In this study, we identified MLK4, a member of the MAP3K family, as a regulator of TAM-driven oncogenic processes in TNBC. Using a co-culture of TNBC cells with macrophages, we demonstrated that high MLK4 expression in TNBC is essential for macrophage-induced cancer cell proliferation, extracellular matrix (ECM) remodeling, migration, and invasion. Mechanistically, we showed that the cross-talk between TAMs and TNBC cells drives tumor aggressiveness via an MLK4-dependent mechanism by enhancing NF-κB activation and downstream matrix metalloproteinases (MMPs) expression. We also identified the most prominently upregulated factors, including CXCL1 and IL-8, during the co-culture of macrophages and TNBC cells. We further showed that MLK4 expression correlates with increased macrophage infiltration in TNBC patient samples, indicating its potential role in shaping the immunosuppressive tumor microenvironment. Summarizing, our findings uncover a paracrine signaling involving CXCL1 and MLK4-NF-κB-MMPs axis, which mediates the interactions between TAMs and TNBC cells, enhancing proliferation, mesenchymal transition, ECM remodeling and cancer invasion. This work elucidates a new mechanism of macrophage-induced tumor progression and highlights MLK4 as a promising therapeutic target for disrupting cancer cells-macrophage reciprocal communication in TNBC.
- 1 April 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessMLK4 orchestrates macrophage-induced triple-negative breast cancer invasion and ECM remodeling via enhanced paracrine signaling and NF-κB-MMP axis activation
Tumor-associated macrophages (TAMs) are important mediators of triple-negative breast cancer (TNBC) progression, yet the molecular mechanisms driving this process remain incompletely defined. In this study, we identified MLK4, a member of the MAP3K family, as a regulator of TAM-driven oncogenic processes in TNBC. Using a co-culture of TNBC cells with macrophages, we demonstrated that high MLK4 expression in TNBC is essential for macrophage-induced cancer cell proliferation, extracellular matrix (ECM) remodeling, migration, and invasion. Mechanistically, we showed that the cross-talk between TAMs and TNBC cells drives tumor aggressiveness via an MLK4-dependent mechanism by enhancing NF-κB activation and downstream matrix metalloproteinases (MMPs) expression. We also identified the most prominently upregulated factors, including CXCL1 and IL-8, during the co-culture of macrophages and TNBC cells. We further showed that MLK4 expression correlates with increased macrophage infiltration in TNBC patient samples, indicating its potential role in shaping the immunosuppressive tumor microenvironment. Summarizing, our findings uncover a paracrine signaling involving CXCL1 and MLK4-NF-κB-MMPs axis, which mediates the interactions between TAMs and TNBC cells, enhancing proliferation, mesenchymal transition, ECM remodeling and cancer invasion. This work elucidates a new mechanism of macrophage-induced tumor progression and highlights MLK4 as a promising therapeutic target for disrupting cancer cells-macrophage reciprocal communication in TNBC.
- Open Access
- 1 December 2021
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 10 (2) , 228-244
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress
Oxidative stress, caused by the imbalance between reactive species generation and the dysfunctional capacity of antioxidant defenses, is one of the characteristic features of cancer. Here, we quantified hydrogen peroxide in the tumor microenvironment (TME) and demonstrated that hydrogen peroxide concentrations are elevated in tumor interstitial fluid isolated from murine breast cancers in vivo, when compared with blood or normal subcutaneous fluid. Therefore, we investigated the effects of increased hydrogen peroxide concentration on immune cell functions. NK cells were more susceptible to hydrogen peroxide than T cells or B cells, and by comparing T, B, and NK cells' sensitivities to redox stress and their antioxidant capacities, we identified peroxiredoxin-1 (PRDX1) as a lacking element of NK cells' antioxidative defense. We observed that priming with IL15 protected NK cells' functions in the presence of high hydrogen peroxide and simultaneously upregulated PRDX1 expression. However, the effect of IL15 on PRDX1 expression was transient and strictly dependent on the presence of the cytokine. Therefore, we genetically modified NK cells to stably overexpress PRDX1, which led to increased survival and NK cell activity in redox stress conditions. Finally, we generated PD-L1–CAR NK cells overexpressing PRDX1 that displayed potent antitumor activity against breast cancer cells under oxidative stress. These results demonstrate that hydrogen peroxide, at concentrations detected in the TME, suppresses NK cell function and that genetic modification strategies can improve CAR NK cells' resistance and potency against solid tumors.
- 1 December 2021
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 10 (2) , 228-244
Open AccessPRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress
Oxidative stress, caused by the imbalance between reactive species generation and the dysfunctional capacity of antioxidant defenses, is one of the characteristic features of cancer. Here, we quantified hydrogen peroxide in the tumor microenvironment (TME) and demonstrated that hydrogen peroxide concentrations are elevated in tumor interstitial fluid isolated from murine breast cancers in vivo, when compared with blood or normal subcutaneous fluid. Therefore, we investigated the effects of increased hydrogen peroxide concentration on immune cell functions. NK cells were more susceptible to hydrogen peroxide than T cells or B cells, and by comparing T, B, and NK cells' sensitivities to redox stress and their antioxidant capacities, we identified peroxiredoxin-1 (PRDX1) as a lacking element of NK cells' antioxidative defense. We observed that priming with IL15 protected NK cells' functions in the presence of high hydrogen peroxide and simultaneously upregulated PRDX1 expression. However, the effect of IL15 on PRDX1 expression was transient and strictly dependent on the presence of the cytokine. Therefore, we genetically modified NK cells to stably overexpress PRDX1, which led to increased survival and NK cell activity in redox stress conditions. Finally, we generated PD-L1–CAR NK cells overexpressing PRDX1 that displayed potent antitumor activity against breast cancer cells under oxidative stress. These results demonstrate that hydrogen peroxide, at concentrations detected in the TME, suppresses NK cell function and that genetic modification strategies can improve CAR NK cells' resistance and potency against solid tumors.
- Open Access
- 13 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-14
TBC1D24 emerges as an important contributor to progressive postlingual dominant hearing loss
Several TBC1D24 variants are causally involved in the development of profound, prelingual hearing loss (HL) and different epilepsy syndromes inherited in an autosomal recessive manner. Only two TBC1D24 pathogenic variants have been linked with postlingual progressive autosomal dominant HL (ADHL). To determine the role of TBC1D24 in the development of ADHL and to characterize the TBC1D24-related ADHL, clinical exome sequencing or targeted multigene (n = 237) panel were performed for probands (n = 102) from multigenerational ADHL families. In four families, TBC1D24-related HL was found based on the identification of three novel, likely pathogenic (c.553G>A, p.Asp185Asn; c.1460A>T, p. His487Leu or c.1461C>G, p.His487Gln) and one known (c.533C>T, p.Ser178Leu) TBC1D24 variant. Functional consequences of these variants were characterized by analyzing the proposed homology models of the human TBC1D24 protein. Variants not only in the TBC (p.Ser178Leu, p.Asp185Asn) but also in the TLDc domain (p.His487Gln, p.His487Leu) are involved in ADHL development, the latter two mutations probably affecting interactions between the domains. Clinically, progressive HL involving mainly mid and high frequencies was observed in the patients (n = 29). The progression of HL was calculated by constructing age-related typical audiograms. TBC1D24-related ADHL originates from the cochlear component of the auditory system, becomes apparent usually in the second decade of life and accounts for approximately 4% of ADHL cases. Given the high genetic heterogeneity of ADHL, TBC1D24 emerges as an important contributor to this type of HL.
- 13 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-14
Open AccessTBC1D24 emerges as an important contributor to progressive postlingual dominant hearing loss
Several TBC1D24 variants are causally involved in the development of profound, prelingual hearing loss (HL) and different epilepsy syndromes inherited in an autosomal recessive manner. Only two TBC1D24 pathogenic variants have been linked with postlingual progressive autosomal dominant HL (ADHL). To determine the role of TBC1D24 in the development of ADHL and to characterize the TBC1D24-related ADHL, clinical exome sequencing or targeted multigene (n = 237) panel were performed for probands (n = 102) from multigenerational ADHL families. In four families, TBC1D24-related HL was found based on the identification of three novel, likely pathogenic (c.553G>A, p.Asp185Asn; c.1460A>T, p. His487Leu or c.1461C>G, p.His487Gln) and one known (c.533C>T, p.Ser178Leu) TBC1D24 variant. Functional consequences of these variants were characterized by analyzing the proposed homology models of the human TBC1D24 protein. Variants not only in the TBC (p.Ser178Leu, p.Asp185Asn) but also in the TLDc domain (p.His487Gln, p.His487Leu) are involved in ADHL development, the latter two mutations probably affecting interactions between the domains. Clinically, progressive HL involving mainly mid and high frequencies was observed in the patients (n = 29). The progression of HL was calculated by constructing age-related typical audiograms. TBC1D24-related ADHL originates from the cochlear component of the auditory system, becomes apparent usually in the second decade of life and accounts for approximately 4% of ADHL cases. Given the high genetic heterogeneity of ADHL, TBC1D24 emerges as an important contributor to this type of HL.
- Open Access
- 16 August 2012
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 26 (17) , 1911-1925
C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3′ end modification
C16orf57encodes a human protein of unknown function, and mutations in the gene occur in poikiloderma with neutropenia (PN), which is a rare, autosomal recessive disease. Interestingly, mutations inC16orf57were also observed among patients diagnosed with Rothmund-Thomson syndrome (RTS) and dyskeratosis congenita (DC), which are caused by mutations in genes involved in DNA repair and telomere maintenance. A genetic screen inSaccharomyces cerevisiaerevealed that the yeast ortholog ofC16orf57,USB1(YLR132C), is essential for U6 small nuclear RNA (snRNA) biogenesis and cell viability. Usb1 depletion destabilized U6 snRNA, leading to splicing defects and cell growth defects, which was suppressed by the presence of multiple copies of the U6 snRNA geneSNR6. Moreover, Usb1 is essential for the generation of a unique feature of U6 snRNA; namely, the 3′-terminal phosphate. RNAi experiments in human cells followed by biochemical and functional analyses confirmed that, similar to yeast,C16orf57encodes a protein involved in the 2′,3′-cyclic phosphate formation at the 3′ end of U6 snRNA. Advanced bioinformatics predicted thatC16orf57encodes a phosphodiesterase whose putative catalytic activity is essential for its function in vivo. Our results predict an unexpected molecular basis for PN, DC, and RTS and provide insight into U6 snRNA 3′ end formation.
- 16 August 2012
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 26 (17) , 1911-1925
Open AccessC16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3′ end modification
C16orf57encodes a human protein of unknown function, and mutations in the gene occur in poikiloderma with neutropenia (PN), which is a rare, autosomal recessive disease. Interestingly, mutations inC16orf57were also observed among patients diagnosed with Rothmund-Thomson syndrome (RTS) and dyskeratosis congenita (DC), which are caused by mutations in genes involved in DNA repair and telomere maintenance. A genetic screen inSaccharomyces cerevisiaerevealed that the yeast ortholog ofC16orf57,USB1(YLR132C), is essential for U6 small nuclear RNA (snRNA) biogenesis and cell viability. Usb1 depletion destabilized U6 snRNA, leading to splicing defects and cell growth defects, which was suppressed by the presence of multiple copies of the U6 snRNA geneSNR6. Moreover, Usb1 is essential for the generation of a unique feature of U6 snRNA; namely, the 3′-terminal phosphate. RNAi experiments in human cells followed by biochemical and functional analyses confirmed that, similar to yeast,C16orf57encodes a protein involved in the 2′,3′-cyclic phosphate formation at the 3′ end of U6 snRNA. Advanced bioinformatics predicted thatC16orf57encodes a phosphodiesterase whose putative catalytic activity is essential for its function in vivo. Our results predict an unexpected molecular basis for PN, DC, and RTS and provide insight into U6 snRNA 3′ end formation.